Shopping Cart 0
Cart Subtotal
USD 0

Lexicon Pharmaceuticals Inc (LXRX) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Lexicon Pharmaceuticals Inc (LXRX)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Lexicon Pharmaceuticals Inc (Lexicon) is a biopharmaceutical company, which focuses on the discovery, development and commercialization of innovative treatments for human diseases. The company has advanced multiple drug candidates into clinical development and has clinical-stage drug program sotagliflozin (LX4211) for type 1 and type 2 diabetes and its approved product Xermelo (telotristat ethyl) for the treatment of carcinoid syndrome. Lexicon's clinical and preclinical development programs, LX2761 and LX9211 are focused at treating diabetes and neuropathic pain respectively. Lexicon has its laboratory at Texas. It has business collaborations with several pharmaceutical and biotechnology companies. Lexicon is headquartered at The Woodlands, Texas, the US.

Lexicon Pharmaceuticals Inc Key Recent Developments

May 03,2018: Lexicon Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides a Business Update

Apr 03,2018: Lexicon Pharmaceuticals to Highlight Pipeline Progress at R&D Day on April 10, 2018

Feb 22,2018: Lexicon Pharmaceuticals Announces Fourth Quarter and Full-year 2017 Financial Results

Nov 08,2017: Lexicon Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides a Business Update

Aug 01,2017: Lexicon Pharmaceuticals Reports Second Quarter 2017 Financial Results And Provides A Business Update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

Lexicon Pharmaceuticals Inc-Key Facts 5

Lexicon Pharmaceuticals Inc-Key Employees 6

Lexicon Pharmaceuticals Inc-Key Employee Biographies 7

Lexicon Pharmaceuticals Inc-Major Products and Services 8

Lexicon Pharmaceuticals Inc-History 9

Lexicon Pharmaceuticals Inc-Company Statement 11

Lexicon Pharmaceuticals Inc-Locations And Subsidiaries 13

Head Office 13

Other Locations & Subsidiaries 13

Section 2-Company Analysis 14

Lexicon Pharmaceuticals Inc-Business Description 14

Lexicon Pharmaceuticals Inc-SWOT Analysis 15

SWOT Analysis-Overview 15

Lexicon Pharmaceuticals Inc-Strengths 15

Lexicon Pharmaceuticals Inc-Weaknesses 16

Lexicon Pharmaceuticals Inc-Opportunities 17

Lexicon Pharmaceuticals Inc-Threats 18

Lexicon Pharmaceuticals Inc-Key Competitors 19

Section 3-Company Financial Ratios 20

Financial Ratios-Capital Market Ratios 20

Financial Ratios-Annual Ratios 21

Performance Chart 24

Financial Performance 24

Financial Ratios-Interim Ratios 25

Financial Ratios-Ratio Charts 26

Section 4-Company's Lifesciences Financial Deals and Alliances 27

Lexicon Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27

Lexicon Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28

Lexicon Pharmaceuticals Inc, Recent Deals Summary 29

Section 5-Company's Recent Developments 30

May 03, 2018: Lexicon Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides a Business Update 30

Apr 03, 2018: Lexicon Pharmaceuticals to Highlight Pipeline Progress at R&D Day on April 10, 2018 32

Nov 08, 2017: Lexicon Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides a Business Update 33

Aug 01, 2017: Lexicon Pharmaceuticals Reports Second Quarter 2017 Financial Results And Provides A Business Update 34

May 02, 2017: Lexicon Pharmaceuticals Reports First Quarter 2017 Financial Results And Provides A Business Update 36

Mar 03, 2017: Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2016 Fourth Quarter And Full Year Financial Results 38

Section 6-Appendix 40

Methodology 40

Ratio Definitions 40

About GlobalData 44

Contact Us 44

Disclaimer 44


List Of Figure

List of Figures

Lexicon Pharmaceuticals Inc, Performance Chart (2013-2017) 24

Lexicon Pharmaceuticals Inc, Ratio Charts 26

Lexicon Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27

Lexicon Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 28


List Of Table

List of Tables

Lexicon Pharmaceuticals Inc, Key Facts 5

Lexicon Pharmaceuticals Inc, Key Employees 6

Lexicon Pharmaceuticals Inc, Key Employee Biographies 7

Lexicon Pharmaceuticals Inc, Major Products and Services 8

Lexicon Pharmaceuticals Inc, History 9

Lexicon Pharmaceuticals Inc, Subsidiaries 13

Lexicon Pharmaceuticals Inc, Key Competitors 19

Lexicon Pharmaceuticals Inc, Ratios based on current share price 20

Lexicon Pharmaceuticals Inc, Annual Ratios 21

Lexicon Pharmaceuticals Inc, Annual Ratios (Cont...1) 22

Lexicon Pharmaceuticals Inc, Annual Ratios (Cont...2) 23

Lexicon Pharmaceuticals Inc, Interim Ratios 25

Lexicon Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27

Lexicon Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28

Lexicon Pharmaceuticals Inc, Recent Deals Summary 29

Currency Codes 40

Capital Market Ratios 40

Equity Ratios 41

Profitability Ratios 41

Cost Ratios 42

Liquidity Ratios 42

Leverage Ratios 43

Efficiency Ratios 43

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Lexicon Pharmaceuticals Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Novelion Therapeutics Inc

Natural Health Trends Corp

Geron Corp

Dyax Corp

Acorda Therapeutics Inc